OP-2024-001 Study
Phase 1
- Conditions
- Parkinson's disease
- Registration Number
- JPRN-jRCT2071210039
- Lead Sponsor
- Taguchi Fumi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
1) Healthy Japanese male.
2) Those with age >= 20 to <= 40 years.
3) Those with BMI >= 18.5 to < 25.0.
4) Those who have provided voluntary written consent to participate in the study.
Exclusion Criteria
1) Those with a history of allergies to investigational drug ingredients, drugs, or foods
2) Those who are undergoing treatment for, or have a history of, respiratory, circulatory, central nervous system, gastrointestinal, hepatic, renal, hematopoietic, or endocrine disorders that affect pharmacokinetics
3) Other protocol defined exclusion criteria could apply
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method